https://www.avient.com/sites/default/files/2020-10/tpes-for-automotive-hvac-product-bulletin.pdf
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/sites/default/files/2020-09/chemically-compatible-tpes-for-cosmetic-pkg-application-bulletin.pdf
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/sites/default/files/2020-10/wire-cable-1-pager.pdf
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/sites/default/files/resources/Application%2520Bulletin%2520Resilience%2520HC.pdf
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
PolyOne conducted a comparative study of polymer resistance to three common, harsh disinfectant chemistries.
https://www.avient.com/sites/default/files/resources/Forward%2520Looking%2520Statements%2520and%2520Non%2520GAAP%2520Measures.pdf
• Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: � Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; � The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; � The speed and extent of an economic recovery, including the recovery of the housing market; � The amount and timing of repurchases, if any, of PolyOne common shares and our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; � The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks; Changes in polymer consumption growth rates in the markets where we conduct business; Forward Looking Statements � Changes in polymer consumption growth rates in the markets where we conduct business; � Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; � Fluctuations in raw material prices, quality and supply and in energy prices and supply; � Production outages or material costs associated with scheduled or unscheduled maintenance programs; � Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; � An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services; � The ability to successfully integrate acquired companies into our operations, retain the management teams of acquired companies, and retain relationships with customers of acquired companies, including without limitation, Color Matrix Group, Inc.
https://www.avient.com/sites/default/files/2020-08/wilflex-ghosting-tips-techniques.pdf
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/sites/default/files/2021-04/bergamid-seat-fastener-case-study.pdf
Among the required properties were high strength and stiffness, impact resistance, moderate temperature resistance and low warpage.
This material offers the stiffness and high impact performance required to support and secure multiple electronic attachments, and provides the impact and temperature resistance needed.
https://www.avient.com/sites/default/files/2025-02/31307-Certificate-17JUL2024.pdf
Purchasing, Customer Service, Logistics, Quality, Design and Sampling; Corporate HQ, Management of QMS 33587, Walker Road, Building 428 Avon Lake - OH 44012 United States Avient Corporation - Avon Lake, OH (SEM) Manufacture of Engineered Thermoplastics , 554 Moore Road Avon Lake - OH 44012 United States Avient Corporation - Aland (Odkarby), Finland Manufacture of colorants and compounds for fluoropolymer and high temperature polymers Kroklundsvagen 346 AX-22320 Ödkarby Finland Avient Corporation - Alicante (Ibi - IQAP), Spain Design, development and production of color concentrates and additives for plastic and synthetic fibers Guadalajara 6, Poligono Industrial L'Alfalç 03440 Ibi Spain Avient Corporation - Assesse, Belgium (CAI & SEM) "Design of color concentrates, precolors, and compounds for fluoropolymer and high temperature polymers, LSFOH (low smoke and fume, zero halogen compounds), and Specialty Compounds Manufacture of Color and Additive Concentrates and Specialty Compounds" 2 Rue Melville Wilson 5330 Assesse Belgium Avient Corporation - Barbastro Design and Manufacture of Specialty Engineered Thermoplastics Pol.
Rocky River Drive Berea - OH 44017 United States Avient Corporation - Bethel, CT Design and Manufacture of colorants and compounds for fluoropolymer and high temperature polymers. , 19 Francis J Clark Circle Bethel - CT 06801 United States Copyright as of the Effective Date, ABS Quality Evaluations, Inc.
https://www.avient.com/sites/default/files/2023-10/31307-Certificate-20SEP2023.pdf
Facility: Avient Corporation - Assesse, Belgium (CAI & SEM) 2 Rue Melville Wilson Assesse 5330 Belgium Activity: Liquid Colorants and Additives for Plastics Activity: "Design of color concentrates, precolors, and compounds for fluoropolymer and high temperature polymers, LSFOH (low smoke and fume, zero halogen compounds), and Specialty Compounds Manufacture of Color and Additive Concentrates and Specialty Compounds" Page 6 of 7 ABS Quality Evaluations Avient Corporation ISO 9001:2015 Certificate Of Conformance ANNEX At Below Facilities: Validity of this certificate may be confirmed at www.abs-qe.com/cert_validation.
Activity: Manufacture of colorants and compounds for fluoropolymer and high temperature polymers Activity: Design and Manufacture of colorants and compounds for fluoropolymer and high temperature polymers.
https://www.avient.com/sites/default/files/2022-05/Compensation Committee Charter (REV 10-2019).pdf
• Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by the independent compensation consultant. • In determining the long-term incentive component of the Chief Executive Officer’s compensation, consider the Company’s performance and relative shareholder return, the value of similar incentive awards to chief executive officers at comparable companies, and the awards given to the Chief Executive Officer in the past. • Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate. • In evaluating and making recommendations regarding, or determining and approving, executive compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation (“Say on Pay Vote”) required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). • With respect to incentive compensation plans and equity-based plans: • Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • Review and approve equity-based grants and awards, including long-term incentive plan awards, to officers, senior managers, key employees, and other employees of the Company and its subsidiaries under the Company’s equity-based plans. • Review and approve the performance criteria, target awards, payout criteria and like items for the Company’s annual incentive and long-term incentive compensation plans. • Review and approve (a) attainment levels under the Company’s annual incentive plan; (b) payments to executive officers of the Company under the annual incentive plan; and (c) payments to officers, senior managers and employees of the Company under the Company’s long-term incentive compensation plans. • Administer the Company’s equity-based incentive compensation plans and other plans adopted by the Board that contemplate administration by the Committee. • Review and approve special bonuses and/or other awards to executive officers on a case-by- case basis for outstanding performance. • Review and approve the terms of all employment agreements, management continuity agreements and change in control agreements for elected officers. 3 Non-employee Director Compensation. • Review the compensation of non-employee directors and make recommendations to the Board regarding changes to existing compensation levels. • Perform administrative functions with respect to the compensation of non-employee directors, including interpreting existing policy. • Review and approve (or approve and recommend to the Board for its approval) equity-based grants and awards to non-employee directors under the Company’s equity-based plans.
Oversee Regulatory Compliance; Governance. • Review and assess risks arising from the Company’s compensation policies and practices for its executive officers and employees, and whether any such risks are reasonably likely to have a material adverse effect on the Company. • In consultation with appropriate officers of the Company, oversee regulatory compliance with respect to compensation matters, including with respect to applicable tax laws. • Review and recommend to the Board for approval the frequency with which the Company will conduct Say on Pay Votes, taking into account the results of the most recent shareholder advisory vote on the frequency of Say on Pay Votes required by Section 14A of the Exchange Act, and review and approve the proposals regarding the Say on Pay Vote and the frequency of the Say on Pay Vote to be included in the Company's proxy statement.
Review and Discuss the CD&A and Compensation Committee Report. • With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation. • Regularly report the Committee’s activities and any recommendations to the Board in such manner and at such times as the Committee or the Board deems appropriate. • Conduct an annual evaluation of the Committee’s performance.